NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with Irish Pharmacist includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

ADVERTISMENT

ADVERTISMENT

Female health conditions under-represented in studies — HRB review

By Irish Pharmacist - 03rd Nov 2025

Female
Image: iStock.com

There are substantial gaps in understanding of conditions affecting women, including early pregnancy loss and mental health after childbirth, a new Health Research Board (HRB) report has found.

Women’s Health Treatment Interventions and Outcomes: An Evidence and Gap Map Review found there were no intervention studies conducted in Ireland relating to these conditions, along with vaginosis and prolapse.

The review, requested by the Department of Health as part of the Women’s Health Action Plan 2024-2025, examined 2,279 English-language studies published between January 2019 and February 2024 in 38 OECD countries, including Ireland.

It examined 10 categories of conditions that exclusively or mainly affect women:

  • Abnormal menses/symptoms.
  • Cancers of the female reproductive tract.
  • Gynaecological-related conditions/pain.
  • Menopausal symptoms.
  • Pelvic floor disorders.
  • Pelvic organ prolapse.
  • Pelvic and vulvar vaginosis.
  • Female infertility.
  • Early pregnancy loss (<20 weeks).
  • Postpartum mental health.

These were selected based on research with women in Ireland that identified these conditions as important and based on a framework of chronic conditions in women developed by the USA’s National Institutes of Health.

Apart from cancers of the female reproductive tract, four intervention studies or less have been conducted in Ireland on each of the remaining health conditions reviewed.

The four health conditions for which there are no intervention studies conducted in Ireland are also the least studied across Organisation for Economic Co-operation and Development (OECD) countries. The review noted this reflects under- representation of female-specific conditions in clinical research.

Lead author of the report Dr Jane Murphy said: “These findings underscore the clear need to strengthen the evidence base for conditions that have a profound impact on women’s lives but remain under-researched. Without comprehensive evidence, we cannot provide optimal care and support to women on a national and international level.”

Of the 10 health condition categories, the five health condition categories with the highest number of studies across OECD countries between January 2019 and February 2024 were: Gynaecological-related conditions/pain; cancers of the female reproductive tract; female infertility; pelvic floor disorders; and menopausal symptoms.

The HRB review also found that while most condition-specific core outcomes were reported in the identified studies, several outcomes were missing, including menstrual regularity in adenomyosis, mortality in ectopic pregnancy and miscarriage, suicidal thoughts, attempted suicide, and thoughts of harming the baby in postpartum depression.

ADVERTISMENT

Latest

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT

Latest Issue

Irish Pharmacist November 2025

Irish Pharmacist November 2025

Irish Pharmacist November 2025. Read the latest news in the Irish Pharmacy industry…

Read
OTC Update Summer 2025

OTC Update Summer 2025

OTC Update Summer 2025

Read

ADVERTISMENT

In Focus

ADVERTISMENT

ADVERTISMENT

ADVERTISMENT